Cargando…

Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study

Detalles Bibliográficos
Autores principales: Batista, José Gomes, Soares, José Maria, Maganhin, Carla Cristina, Simões, Ricardo Santos, Tomaz, Geraldez, Baracat, Edmund Chada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297040/
https://www.ncbi.nlm.nih.gov/pubmed/22473412
http://dx.doi.org/10.6061/clinics/2012(03)14
_version_ 1782225819941208064
author Batista, José Gomes
Soares, José Maria
Maganhin, Carla Cristina
Simões, Ricardo Santos
Tomaz, Geraldez
Baracat, Edmund Chada
author_facet Batista, José Gomes
Soares, José Maria
Maganhin, Carla Cristina
Simões, Ricardo Santos
Tomaz, Geraldez
Baracat, Edmund Chada
author_sort Batista, José Gomes
collection PubMed
description
format Online
Article
Text
id pubmed-3297040
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-32970402012-03-08 Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study Batista, José Gomes Soares, José Maria Maganhin, Carla Cristina Simões, Ricardo Santos Tomaz, Geraldez Baracat, Edmund Chada Clinics (Sao Paulo) Rapid Communication Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2012-03 /pmc/articles/PMC3297040/ /pubmed/22473412 http://dx.doi.org/10.6061/clinics/2012(03)14 Text en Copyright © 2012 Hospital das Clínicas da FMUSP http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Rapid Communication
Batista, José Gomes
Soares, José Maria
Maganhin, Carla Cristina
Simões, Ricardo Santos
Tomaz, Geraldez
Baracat, Edmund Chada
Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study
title Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study
title_full Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study
title_fullStr Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study
title_full_unstemmed Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study
title_short Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study
title_sort assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297040/
https://www.ncbi.nlm.nih.gov/pubmed/22473412
http://dx.doi.org/10.6061/clinics/2012(03)14
work_keys_str_mv AT batistajosegomes assessingthebenefitsofrosiglitazoneinwomenwithpolycysticovarysyndromethroughitseffectsoninsulinlikegrowthfactor1insulinlikegrowthfactorbindingprotein3andinsulinresistanceapilotstudy
AT soaresjosemaria assessingthebenefitsofrosiglitazoneinwomenwithpolycysticovarysyndromethroughitseffectsoninsulinlikegrowthfactor1insulinlikegrowthfactorbindingprotein3andinsulinresistanceapilotstudy
AT maganhincarlacristina assessingthebenefitsofrosiglitazoneinwomenwithpolycysticovarysyndromethroughitseffectsoninsulinlikegrowthfactor1insulinlikegrowthfactorbindingprotein3andinsulinresistanceapilotstudy
AT simoesricardosantos assessingthebenefitsofrosiglitazoneinwomenwithpolycysticovarysyndromethroughitseffectsoninsulinlikegrowthfactor1insulinlikegrowthfactorbindingprotein3andinsulinresistanceapilotstudy
AT tomazgeraldez assessingthebenefitsofrosiglitazoneinwomenwithpolycysticovarysyndromethroughitseffectsoninsulinlikegrowthfactor1insulinlikegrowthfactorbindingprotein3andinsulinresistanceapilotstudy
AT baracatedmundchada assessingthebenefitsofrosiglitazoneinwomenwithpolycysticovarysyndromethroughitseffectsoninsulinlikegrowthfactor1insulinlikegrowthfactorbindingprotein3andinsulinresistanceapilotstudy